Inventor · disambiguated record
Sarah Strong
Also filed as: STRONG SARAH · STRONG SARAH A
24 granted patents·1 pending application·472 citations·filing 2003–2016
96Inventor score
Files withN30 PHARMACEUTICALS INC6GUILES JOSEPH5WASLEY JAN4COLEY PHARM GROUP INC33M INNOVATIVE PROPERTIES CO2
Top patents by PatentIndex Score
25 records- 0198US7544697B2Pyrazolopyridines and analogs thereofCOLEY PHARM GROUP INC·Filed 2005·Granted Jun 9, 2009·100 cites·11 claims
- 0297US7879849B2Pyrazolopyridines and analogs thereof3M INNOVATIVE PROPERTIES CO·Filed 2009·Granted Feb 1, 2011·57 cites·20 claims
- 0396US7598382B2Aryl substituted imidazoquinolinesCOLEY PHARM GROUP INC·Filed 2006·Granted Oct 6, 2009·80 cites·6 claims
- 0496US7091214B2Aryl substituted Imidazoquinolines3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Aug 15, 2006·96 cites·27 claims
- 0594US8148380B2Antibacterial amide and sulfonamide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Apr 3, 2012·46 cites·23 claims
- 0690US8691816B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Apr 8, 2014·11 cites·28 claims
- 0790US8470857B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Jun 25, 2013·13 cites·7 claims
- 0888US8673961B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Mar 18, 2014·7 cites·17 claims
- 0986US9180119B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2015·Granted Nov 10, 2015·4 cites·19 claims
- 1086US8957105B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Feb 17, 2015·5 cites·19 claims
- 1186US8686015B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2013·Granted Apr 1, 2014·7 cites·8 claims
- 1286US8642628B2Pyrrole inhibitors of S-nitrosoglutathione reductaseWASLEY JAN·Filed 2009·Granted Feb 4, 2014·8 cites·8 claims
- 1385US9138427B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·5 cites·19 claims
- 1484US8846736B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Sep 30, 2014·5 cites·8 claims
- 1584US7973050B2Enantiomeric compounds with antibacterial activityCRESTONE INC·Filed 2007·Granted Jul 5, 2011·5 cites·9 claims
- 1683US8716320B2Antibacteriall heterocyclic ureasGUILES JOSEPH·Filed 2007·Granted May 6, 2014·4 cites·25 claims
- 1780US9145410B2Pyrazolopyridines and analogs thereofHAYS DAVID S·Filed 2012·Granted Sep 29, 2015·5 cites·17 claims
- 1880US9029402B2Pyrrole inhibitors of S-nitrosoglutathione reductaseN30 PHARMACEUTICALS INC·Filed 2014·Granted May 12, 2015·4 cites·11 claims
- 1979US8293919B2Antibacterial sulfone and sulfoxide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Oct 23, 2012·4 cites·19 claims
- 2078US7994192B2Substituted thienopyridone compounds with antibacterial activityCRESTONE INC·Filed 2007·Granted Aug 9, 2011·4 cites·6 claims
- 2175US9498466B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Nov 22, 2016·1 cites·11 claims
- 2272US8697720B2Substituted phenylether-thienopyridone compounds with antibacterial activityGUILES JOSEPH·Filed 2007·Granted Apr 15, 2014·1 cites·7 claims
- 2363US9814700B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·21 claims
- 2459US8658670B2Methods and compounds for treatment of clostridium based infectionGUILES JOSEPH·Filed 2007·Granted Feb 25, 2014·0 cites·2 claims
- 2547US2009075980A1Pyrazolopyridines and Analogs ThereofCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarah Strong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →